REGN logo

Regeneron Pharmaceuticals (REGN) Total Debt

Annual Total Debt

$2.70 B
+$1.50 M+0.06%

31 December 2023

REGN Total Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Debt

$2.70 B
+$400.00 K+0.01%

30 September 2024

REGN Quarterly Total Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

REGN Total Debt Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+0.1%+0.1%
3 y3 years+0.3%+0.2%
5 y5 years+281.5%+279.4%

REGN Total Debt High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+0.3%at high+0.2%
5 y5 yearsat high+281.5%at high+279.4%
alltimeall timeat highat high

Regeneron Pharmaceuticals Total Debt History

DateAnnualQuarterly
Sept 2024
-
$2.70 B(+0.0%)
June 2024
-
$2.70 B(+0.0%)
Mar 2024
-
$2.70 B(+0.0%)
Dec 2023
$2.70 B(+0.1%)
$2.70 B(+0.0%)
Sept 2023
-
$2.70 B(+0.0%)
June 2023
-
$2.70 B(+0.0%)
Mar 2023
-
$2.70 B(+0.0%)
Dec 2022
$2.70 B(+0.1%)
$2.70 B(+0.0%)
Sept 2022
-
$2.70 B(+0.0%)
June 2022
-
$2.70 B(+0.0%)
Mar 2022
-
$2.70 B(+0.0%)
Dec 2021
$2.70 B(+0.1%)
$2.70 B(+0.0%)
Sept 2021
-
$2.70 B(+0.0%)
June 2021
-
$2.70 B(+0.0%)
Mar 2021
-
$2.70 B(+0.0%)
Dec 2020
$2.70 B(+277.6%)
$2.70 B(+0.0%)
Sept 2020
-
$2.69 B(+21.6%)
June 2020
-
$2.22 B(+209.8%)
Mar 2020
-
$715.20 M(+0.2%)
Dec 2019
$713.90 M(+0.8%)
$713.90 M(+0.2%)
Sept 2019
-
$712.70 M(+0.2%)
June 2019
-
$711.30 M(+0.2%)
Mar 2019
-
$709.90 M(+0.2%)
Dec 2018
$708.50 M(+0.7%)
$708.50 M(+0.2%)
Sept 2018
-
$707.20 M(+0.2%)
June 2018
-
$705.90 M(+0.2%)
Mar 2018
-
$704.64 M(+0.2%)
Dec 2017
$703.50 M(+46.2%)
$703.50 M(+0.2%)
Sept 2017
-
$702.32 M(+0.2%)
June 2017
-
$701.17 M(-0.9%)
Mar 2017
-
$707.61 M(+47.1%)
Dec 2016
$481.13 M(+32.6%)
$481.13 M(+25.9%)
Sept 2016
-
$382.23 M(+5.7%)
June 2016
-
$361.52 M(-0.2%)
Mar 2016
-
$362.23 M(-0.2%)
Dec 2015
$362.92 M(-20.7%)
$362.92 M(-8.1%)
Sept 2015
-
$394.87 M(+1.8%)
June 2015
-
$388.05 M(-17.9%)
Mar 2015
-
$472.48 M(+3.2%)
Dec 2014
$457.71 M(-9.3%)
$457.71 M(-19.0%)
Sept 2014
-
$565.31 M(+9.2%)
June 2014
-
$517.85 M(-2.5%)
Mar 2014
-
$531.11 M(+5.3%)
Dec 2013
$504.57 M(+10.3%)
$504.57 M(+4.6%)
Sept 2013
-
$482.18 M(+1.9%)
June 2013
-
$473.30 M(+2.3%)
Mar 2013
-
$462.75 M(+1.2%)
Dec 2012
$457.33 M(+5.0%)
$457.33 M(+1.2%)
Sept 2012
-
$451.74 M(+1.2%)
June 2012
-
$446.23 M(+1.2%)
Mar 2012
-
$440.83 M(+1.2%)
Dec 2011
$435.53 M(+172.2%)
$435.53 M(+171.5%)
Sept 2011
-
$160.40 M(+0.0%)
June 2011
-
$160.33 M(+0.1%)
Mar 2011
-
$160.15 M(+0.1%)
Dec 2010
$160.03 M(+46.8%)
$160.03 M(+0.6%)
Sept 2010
-
$159.02 M(+0.8%)
June 2010
-
$157.81 M(+0.6%)
Mar 2010
-
$156.90 M(+43.9%)
Dec 2009
$109.02 M(>+9900.0%)
$109.02 M(+74.2%)
Sept 2009
-
$62.57 M(-0.6%)
June 2009
-
$62.92 M(>+9900.0%)
Mar 2009
-
$0.00(0.0%)
Dec 2008
$0.00(-100.0%)
$0.00(-100.0%)
Sept 2008
-
$117.50 M(-1.0%)
June 2008
-
$118.65 M(-40.7%)
Mar 2008
-
$200.00 M(0.0%)
Dec 2007
$200.00 M
$200.00 M(0.0%)
Sept 2007
-
$200.00 M(0.0%)
DateAnnualQuarterly
June 2007
-
$200.00 M(0.0%)
Mar 2007
-
$200.00 M(0.0%)
Dec 2006
$200.00 M(0.0%)
$200.00 M(0.0%)
Sept 2006
-
$200.00 M(0.0%)
June 2006
-
$200.00 M(0.0%)
Mar 2006
-
$200.00 M(0.0%)
Dec 2005
$200.00 M(0.0%)
$200.00 M(0.0%)
Sept 2005
-
$200.00 M(0.0%)
June 2005
-
$200.00 M(0.0%)
Mar 2005
-
$200.00 M(0.0%)
Dec 2004
$200.00 M(-6.5%)
$200.00 M(0.0%)
Sept 2004
-
$200.00 M(0.0%)
June 2004
-
$200.00 M(0.0%)
Mar 2004
-
$200.00 M(-6.5%)
Dec 2003
$213.82 M(+6.8%)
$213.82 M(+2.2%)
Sept 2003
-
$209.30 M(+2.0%)
June 2003
-
$205.15 M(+2.5%)
Mar 2003
-
$200.06 M(-0.0%)
Dec 2002
$200.15 M(-0.2%)
$200.15 M(-0.0%)
Sept 2002
-
$200.24 M(-0.0%)
June 2002
-
$200.32 M(-0.1%)
Mar 2002
-
$200.47 M(-0.1%)
Dec 2001
$200.58 M(+7381.4%)
$200.58 M(+9147.4%)
Sept 2001
-
$2.17 M(-6.4%)
June 2001
-
$2.32 M(-5.5%)
Mar 2001
-
$2.45 M(-8.6%)
Dec 2000
$2.68 M(-34.6%)
$2.68 M(-10.7%)
Sept 2000
-
$3.00 M(-12.8%)
June 2000
-
$3.44 M(-11.1%)
Mar 2000
-
$3.87 M(-5.6%)
Dec 1999
$4.10 M(-2.4%)
$4.10 M(+24.2%)
Sept 1999
-
$3.30 M(-10.8%)
June 1999
-
$3.70 M(-5.1%)
Mar 1999
-
$3.90 M(-7.1%)
Dec 1998
$4.20 M(-25.0%)
$4.20 M(-6.7%)
Sept 1998
-
$4.50 M(-6.3%)
June 1998
-
$4.80 M(0.0%)
Mar 1998
-
$4.80 M(-14.3%)
Dec 1997
$5.60 M(-35.6%)
$5.60 M(-17.6%)
Sept 1997
-
$6.80 M(-6.8%)
June 1997
-
$7.30 M(-6.4%)
Mar 1997
-
$7.80 M(-10.3%)
Dec 1996
$8.70 M(-8.4%)
$8.70 M(-3.3%)
Sept 1996
-
$9.00 M(+4.7%)
June 1996
-
$8.60 M(-1.1%)
Mar 1996
-
$8.70 M(-8.4%)
Dec 1995
$9.50 M(-22.8%)
$9.50 M(-7.8%)
Sept 1995
-
$10.30 M(-6.4%)
June 1995
-
$11.00 M(+26.4%)
Mar 1995
-
$8.70 M(-29.3%)
Dec 1994
$12.30 M(+64.0%)
$12.30 M(+19.4%)
Sept 1994
-
$10.30 M(+9.6%)
June 1994
-
$9.40 M(-21.0%)
Mar 1994
-
$11.90 M(+58.7%)
Dec 1993
$7.50 M(+10.3%)
$7.50 M(-2.6%)
Sept 1993
-
$7.70 M(-1.3%)
June 1993
-
$7.80 M(+1.3%)
Mar 1993
-
$7.70 M(+13.2%)
Dec 1992
$6.80 M(+142.9%)
$6.80 M(+9.7%)
Sept 1992
-
$6.20 M(+8.8%)
June 1992
-
$5.70 M(+18.8%)
Mar 1992
-
$4.80 M(+71.4%)
Dec 1991
$2.80 M(>+9900.0%)
$2.80 M(+250.0%)
Sept 1991
-
$800.00 K(+100.0%)
June 1991
-
$400.00 K(>+9900.0%)
Mar 1991
-
$0.00(0.0%)
Dec 1990
$0.00
$0.00(0.0%)
Sept 1990
-
$0.00(0.0%)
June 1990
-
$0.00(0.0%)
Mar 1990
-
$0.00

FAQ

  • What is Regeneron Pharmaceuticals annual total debt?
  • What is the all time high annual total debt for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals annual total debt year-on-year change?
  • What is Regeneron Pharmaceuticals quarterly total debt?
  • What is the all time high quarterly total debt for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals quarterly total debt year-on-year change?

What is Regeneron Pharmaceuticals annual total debt?

The current annual total debt of REGN is $2.70 B

What is the all time high annual total debt for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high annual total debt is $2.70 B

What is Regeneron Pharmaceuticals annual total debt year-on-year change?

Over the past year, REGN annual total debt has changed by +$1.50 M (+0.06%)

What is Regeneron Pharmaceuticals quarterly total debt?

The current quarterly total debt of REGN is $2.70 B

What is the all time high quarterly total debt for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high quarterly total debt is $2.70 B

What is Regeneron Pharmaceuticals quarterly total debt year-on-year change?

Over the past year, REGN quarterly total debt has changed by +$1.40 M (+0.05%)